scientist hands with injection

Reach Our Drug Product Services Experts:

drugproduct@lonza.com

Download Our Brochure:

Drug Product Services Overview

 

We have created a Drug Product Services offering as part of our drive to enable customers to meet some of the greatest challenges in patient treatment. Together with our existing Development and Drug Substance manufacturing capabilities, our new offering enables us to provide one-stop-shop service solutions for our customers. Drug product services will focus on parenteral dosage forms, including products for injection and infusion for intravenous, subcutaneous, intraocular and other routes of parenteral administration. Services will include options for monocolonal antibodies, other biologics, drug conjugates, peptides and small molecules that require a parenteral dosage form.

Drug Product Services will be available beginning in the fourth quarter of 2016 from laboratories based in Basel (CH), with an initial focus on Formulation Development and Drug Product Analytical Development and Quality Control. Specialized services will also be available for customers, such as particulate identification, characterization and quantification, excipient and surfactant characterization, extractables & leachables assessment and testing of container closure integrity.  

For additional information on our Drug Product Services facility, visit our site page Basel, Switzerland.